By Malvika Gurung Investing.com -- Adani (NS:APSE) Ports & SEZ India’s largest private multi-port operator consolidated net profit exceeded the Street’s estimate, jumping 68.5% YoY to Rs...
“One should not see Sun Pharma result as a general lifting of pricing pressure and improvement of margin for the entire Indian pharma industry which is having a leg in the US. I will be...
Gross sales came in at Rs 10,809.2 crore, growing by 13.1% over Q2 last year
Ebitda for the quarter came in at Rs 2,956.50 crore, up 12.4% YoY. Ebitda margin fell 30 basis points YoY to 27% from 27.3% in the year-ago quarter.
By Malvika Gurung Investing.com -- The domestic market made a higher opening, extending the previous session’s and multi-day gains on Tuesday, following strong Asian cues amid hopes that the...
Stocks to watch out for today: Sun Pharmaceuticals, Tata Steel, Bharti Airtel, Axis Bank, Adani Power, Capri Global and more
Adani Ports, Chambal Fertilizers, Cholamandalam, Dhanuka, JK Tyre, Kansai Nerolac, Karnataka Bank, LIC Housing Fiaance, Sun Pharma, Tata Investment, Tech Mahindra, UPL, Voltas, Varun...
Among the four companies, Tech Mahindra is expected to report nearly 10 per cent YoY drop in profit. Sun Pharma is seen reporting a marginal fall in profit.
Stocks to watch today: Shares of firms like Sun Pharma, Bharti Airtel, Tata Steel, Equitas SFB, and others will be in focus in Tuesday's trade
Sun Pharma, Adani Ports, TechM, UPL, Voltas, Varun Beverages, Chola Finance, UPL, Macrotech Developers, Max Healthcare, Kansai Nerolac and LIC Housing are among the companies that will...
Stocks to Watch: Check out the companies making headlines before the opening bell.
The operational performance, however, will be hit by higher research and development costs, input prices, and continued erosion in prices in the US generics market. Sun Pharma’s US-based...
SPARC has witnessed a consolidation breakout on the back of robust volumes and surged above all its major EMAs (exponential moving averages) on the daily time frame. Simultaneously, in the...
Analysts remain bullish on market leader Sun Pharma, ahead of its Q2 results
The stock traded higher for the third straight day and has gained nearly 4 per cent during the period. It quoted at its highest level since May 2015.
There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among...
Sun Pharmaceutical Industries is the only other stock among the Sensex 30 and Nifty 50 that trades in the overbought category, technically.
Analysts suggest that select stocks are on the verge of a breakout and buying them can deliver decent gains in the near term
Technically speaking, Sun Pharma prices are continuing with higher highs and higher lows cycle and the way momentum oscillators are poised, we will not be surprised to see this stock...
By Malvika Gurung Investing.com -- The domestic market made a strong opening on Friday, tracking positive cues from global markets, while IT, banking and financial stocks provided...
Top Gainers and Losers of the day (October 13): HCL Tech, Sun Pharma, Wipro, SBI, L&T, ICICI Bank, Dr Reddy's Labs, Reliance Industries and more
"On the daily chart, the Nifty made a bullish harami pattern, suggesting a rise in optimism. Besides, the index has found support at 200-DMA for the second consecutive day. Over the short...
Sanguine prospects and defensive nature put the spotlight back on pharma stocks
Sanghvi holds a 4.2 per cent stake in the wind turbine maker.
Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade
“I would still be cautious through October because the typical parameters which define a sort of bottom formation in the US markets also do not seem to be falling into place at this stage...
Sun Pharma Advanced Research Company Ltd recorded volume of 34.86 lakh shares by 14:14 IST on NSE, a 17.16 times surge over two-week average daily volume of 2.03 lakh shares
Sun Pharma could see structural growth and be relatively insulated from the adverse price erosion scenario in the US, according to analysts.
“ IT is looking good for the simple reason that when the dollar is strongest, it imports disinflation into the US. Earnings growth rate of IT companies for the next three years are likely to...
After a long bearish trend, the pharma indices have recovered from bottom and formed âFlag Pollâ pattern, which suggests bullish strength in pharma sector.
Tracking weak global cues, Indian equities continued to fall for the sixth consecutive day on Wednesday. Nifty ended with a cut of 0.87% at 16859, while Sensex dropped 0.89% to 56,598...
SPARC focuses on discovery and research of novel drugs prioritised in three therapeutic areas i.e. oncology, neurology and immunology. According to the company, during FY22, SPARC raised...
Domestic equity markets saw a steep correction during the fag-end of the previous session as D-Street remained highly volatile. However, various analysts believe that volatile markets give...
Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
"The downside seems to be very limited from here and hence, we advise short term traders to look for buying opportunities in Sun Pharma in the range of Rs 875-865 for potential targets...
Mumbai, Sep 20 (IANS) Benchmark indices ended higher on Tuesday with Sensex rising over 550 points and Nifty over 190 points due to support from Pharma, Auto and Financial stocks, dealers...
Sensex closed 578 points higher at 59,719 and Nifty climbed 194 points to end at 17,816. Sun Pharma, IndusInd Bank, Dr Reddy's and Tata Steel were the top Sensex gainers, rising up to 4.71...
Share market today: Sensex rose 442 points to 59,245 and Nifty closed 126 points higher at 17,665. Of 30 Sensex stocks, 23 ended in the green.
Mumbai, Sep 2 (IANS) The Indian rupee ended 11 paise lower on Thursday to close at 79.56 against the US dollar. At the interbank foreign exchange market, rupee ended at 79.56, as against...
Mumbai, Sep 1 (IANS) Benchmark indices ended sharply down on Thursday in line with international peers with Sensex falling over 700 points and Nifty falling over 200 points. At close, Sensex...
By Malvika Gurung Investing.com -- Shares of many companies, including major public sector heavyweights will trade ex-dividend on Friday, Aug 19. A non-exhaustive list of companies going...
By Malvika Gurung Investing.com -- The domestic market opened the week on a positive note, following the previous week’s rally, supported by gains in auto, financial and oil & gas...
Mumbai, July 29 (IANS) Indian benchmark indices ended higher for the straight third day on Friday and ended the week on the positive note, following the global equity market which continued...
By Malvika Gurung Investing.com -- A slew of companies is lined up to conduct different corporate actions on Friday, including June quarterly earnings announcements and board meetings, among...
By Malvika Gurung Investing.com -- Sun Pharmaceuticals (NS:SUN), Life Insurance Corporation (NS:LIFI): The life insurer has sold a 2% stake or 4.8 crore equity shares of the pharmaceutical...
By Malvika Gurung Investing.com -- The country’s most valued company by market capitalization Reliance Industries (NS:RELI) posted a double-digit bottomline growth, along with the best...
Investing.com – India equities were higher at the close on Tuesday, as gains in the Real Estate, Banking and Auto sectors propelled shares higher. At the close in NSE, the Nifty 50 gained...
Investing.com – India equities were lower at the close on Thursday, as losses in the IT, Technology and Public Sector Undertakings sectors propelled shares lower. At the close in NSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
